A drug-resistant fungus known as Candida auris is spreading across the United States. Health officials have confirmed cases in 23 states this year, with more than 3,000 infections reported so far. This yeast-based threat is labeled an urgent antimicrobial resistance concern by the Centers for Disease Control.
New Jersey has recorded 166 cases of the fungus. While infections occur nationwide, the highest concentration of spread happens within hospitals and nursing homes. The organism travels through contact with infected individuals or contaminated surfaces. Once it enters the bloodstream, it poses a significant risk to those with weakened immune systems.
Symptoms of Candida auris are often generic, which makes early detection difficult for medical professionals. Common indicators include fever, chills, and fatigue. Some patients also experience low body temperature and an elevated heart rate. Because these symptoms mimic other common ailments, identification requires specific diagnostic testing in clinical settings.
Experts note that the fungus is capable of surviving on environmental surfaces for weeks. Standard medical practices, such as isolating infected patients, are currently the primary method for containing outbreaks. While the fatality rate is estimated between 30 and 60 percent, these figures often involve patients already managing other chronic health conditions.
The public should remain aware of the situation, especially when visiting health care facilities. Although the risk to the general public is lower than for those in long-term care, the rapid emergence and speed of transmission remain high-priority concerns for researchers and health agencies across the country.